L1: Lecture_1_Intro_2026_HO__4_
Definitional Perspectives on "Drugs"
Oxford English Dictionary: "Any substance that affects the physical or mental functioning of a living organism."
World Health Organization (WHO): "Chemical entity, or mixture, other than those providing maintenance of normal health (e.g. food) that alters biological functioning."
Historical and Functional Categorizations (Tupper, 2012): - Drug as Medicine ($15$th Century French/Spanish 'drogue/Droga'): A substance used in the prevention or treatment of disease, or a substance that has a physiological effect on a living organism. - Drug as Psychoactive Substance ($17$th Century English): A chemical substance other than a food that alters consciousness when absorbed into the body, regardless of medical use or legal status. - Drug as Dope or Narcotic (End of $1900$s International Control Treaties): A plant or chemical substance that alters human consciousness and has been subjected to rigorous forms of control (e.g., "war on drugs").
Legal Exclusions (UK Psychoactive Substance Act $2016$, Section $2$): Alcohol, tobacco or nicotine-based products, caffeine, food and drink, medicinal products, and drugs already regulated under the Misuse of Drugs Act $1971$.
Drug Classification and Nomenclature
Methods of Classification: - By Source: Naturally occurring (e.g., Opium from poppy, Morphine from opium, cocaine from coca plant, Ephedrine from Ma huang); Semi-synthetics (e.g., Heroin from morphine, LSD from Ergot fungus); Synthetics/Designer drugs (e.g., Methadone, Amphetamine, Fentanyl, MDMA). - By Chemical Structure: e.g., Phenethylamines, Benzenoids. - By Mechanism of Action: e.g., Opioids. - By Therapeutic Use: Analgesics, Anxiolytics, Anti-emetics. - By Prototypical CNS/Behavioral Effect: Stimulants, Depressants, Hallucinogens, Psychotherapeutics. - By Popular/Street Designation or Legal/Social Status.
Prototypical CNS Effects (Psychopharmacology, Box $1.3$): - CNS Stimulants: Amphetamine, Cocaine, Nicotine. - CNS Depressants: Barbiturates, Alcohol. - Analgesics: Morphine, Codeine. - Hallucinogens: Mescaline, LSD, Psilocybin. - Psychotherapeutics: Prozac, Thorazine.
Naming Conventions Example: - Generic: Amphetamine; Chemical: $(\pm)\text{-alpha-methylbenzene-ethylamine}$; Lab Designation: SKF?; Proprietary: Benzedrine®, Dexedrine®, Adderall®; Street: Uppers, Speed. - Generic: Diazepam; Chemical: $7\text{-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one}$; Lab Designation: Ro-$42679$; Proprietary: Valium®; Street: Downer, Tranq. - Generic: Lysergic Acid Diethylamide; Chemical: $(6aR,9R)\text{-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]-quinoline-9-carboxamide}$; Lab Designation: LSD-$25$; Proprietary: Delysid®; Street: Acid, tabs.
Sociolegal Frameworks and Harm
United States Drug Scheduling (DEA): - Schedule I: Most abuse potential, no medicinal qualities (e.g., Heroin, LSD, Marijuana, Ecstasy). - Schedule II: High abuse potential, some medicinal qualities (e.g., Cocaine, Meth, OxyContin, Adderall). - Schedule III: Moderate abuse potential, acceptable medicinal qualities (e.g., Ketamine, Steroids). - Schedule IV: Low abuse potential, acceptable medicinal qualities (e.g., Xanax, Valium). - Schedule V: Lowest abuse potential (e.g., Robitussin AC).
United Kingdom Drug Control Instruments: - Misuse of Drugs Act $1971$: Prevents misuse via bans on possession/supply unless licensed. Uses harm ratings based on Physical harm, Dependence, and Social harm. - Human Medicines Regs $2012$. - Psychoactive Substance Act $2016$.
UK Drug Classification and Penalties: - Class A: Crack cocaine, heroin, ecstasy (MDMA), LSD, magic mushrooms. Possession: Up to $7$ years/fine; Supply: Up to life in prison. - Class B: Amphetamines, cannabis, codeine, ketamine. Possession: Up to $5$ years/fine; Supply: Up to $14$ years. - Class C: Anabolic steroids, benzodiazepines. Possession: Up to $2$ years/fine; Supply: Up to $14$ years. - Temporary Class Drugs: Government can ban new drugs for $1\text{ year}$ (e.g., ethylphenidate derivatives).
Scientific Assessments of Harm (Nutt et al., 2010): - Multi-criteria decision analysis ($16$ criteria including mortality, dependence, and economic cost). - Alcohol was ranked the most harmful drug overall with a score of $72$, followed by Heroin ($55$) and Crack cocaine ($54$). - Disparity exists between scientific harm ratings and legal classifications (e.g., Ecstasy and LSD ranked very low for harm but are Class A).
Drug Use, Abuse, and Addiction
Motivations for Drug Use: - Experimentation/Novelty seeking. - Pleasure (reward/desire). - Self-Medication (relieving anxiety, depression, pain). - Peer pressure.
Spectrum of Use: Drug taking does not always equal addiction. Categories include Experimental, Recreational/Casual, and Circumstantial use.
DSM-IV Criteria for Substance Abuse: Maladaptive pattern leading to impairment/distress manifested by $\geq 1$ criteria over $12\text{ months}$: - Failure to fulfill role obligations. - Use in physically hazardous situations (e.g., driving). - Substance-related legal problems. - Persistent social/interpersonal problems.
DSM-IV Criteria for Substance Dependence: Maladaptive pattern manifested by $\geq 3$ criteria within $12\text{ months}$: - Tolerance: Need for increased amounts or diminished effect of same amount. - Withdrawal: Characteristic syndrome or use to avoid symptoms (Note: neither necessary nor sufficient for addiction). - Taken in larger amounts or longer periods than intended. - Persistent desire/unsuccessful efforts to cut down. - Significant time spent obtaining/using/recovering. - Reduced social/occupational activities. - Continued use despite knowledge of physical/psychological problems caused by it.
DSM-V Changes: - Added a severity scale (mild, moderate, severe). - Included non-drug addictive disorders (gambling). - "Dependence" used only in a pharmacological sense. - Removal of legal criteria. - Added "Craving" to criteria.
Definitions of Addiction: - WHO ($1981$): A syndrome where drug use is given much higher priority than behaviors that once had higher value; associated with compulsive behavior at extremes. - J.H. Jaffe ($1990$): Exhibits characteristics of a "chronic relapsing disorder."